Vaccine Development Related News
C difficile infection: The search for new Clostridioides difficile vaccine
University of Exeter researchers have made a breakthrough in the quest for a new vaccine for killer hospital bug Clostridioides difficile (C difficile infection).
The...
New effective vaccines for Lyme disease are coming
There is no effective vaccine currently available to prevent Lyme disease in humans.
Experts from academia, government, and industry convened at Cold Spring Harbor Laboratory's...
New technology paves the way for needle-free flu vaccine
A new study has shown that a new needle-free flu vaccine patch worked for the immune system much like a traditional flu shot – without any...
Tackling the spread of infectious diseases through vaccinology training in Seoul
The International Vaccine Institute (IVI) is set to help developing countries tackle the spread of infectious diseases by building capacity through vaccinology training in...
Decoding the human immune system with the Human Vaccines Project
Director General Dr Jerome Kim joins the Human Vaccines Project’s efforts as one of four distinguished global leaders to decode the human immune system.
Dr...
Breakthrough monkey malaria study offers cure for relapsing malaria
A breakthrough in monkey malaria research by University of Otago, New Zealand, could help scientists diagnose and treat a form of relapsing malaria.
Published in...
Learn about the nano-vaccine for melanoma that has proven to be effective
Tel Aviv University scientists have developed a novel nano-vaccine for melanoma, whereby injection of nanoparticles has proven effective in mouse models.
Researchers at Tel Aviv...
Maximising vaccine effectiveness for children using genome-wide genotyping
Published in Cell Reports, genetics influence how protective childhood vaccines are, and researchers have found a way of maximising vaccine effectiveness using genome-wide genotyping.
A...
Push to develop world’s first vaccine against the deadly Strep A bacteria
The British biomedical research foundation, the Wellcome Trust, has granted $2.25 million (~€2.1 Million) to IVI & MCRI to coordinate efforts to develop world’s...
Could we be one step closer to global Strep A vaccine?
The search for a global Strep A vaccine has narrowed after researchers sequenced the DNA of more than 2,000 Group A Streptococcus samples from...
Measles resurgence is occurring and getting more difficult to prevent with current vaccination policy
According to a study published in BMC Medicine, across the globe, vaccination policy currently may not be sufficient enough to avert measles resurgence.
Current vaccination...
Discover how millions has been donated to accelerate malaria elimination efforts
Tableau, Mapbox, Exasol, and Alteryx commit $4.3 million (~€3.9 million) to accelerate malaria elimination efforts for more than 60 million people.
Paris, France, 25 April...
Seqirus announces further advances in cell-based influenza vaccine technology
While Seqirus continue to manufacture & distribute egg-based vaccines globally, discover how cell-based influenza vaccine technology represents a significant advancement in protection.
Seqirus, a leading...
Explore the first European framework contracts for influenza pandemic
Seqirus, a global leader in influenza prevention, has announced that it is to supply influenza pandemic vaccines as part of the response to a...
Time to increase the understanding of influenza vaccine effectiveness
There has been a call for researchers to join new efforts to study brand-specific influenza vaccine effectiveness.
A call has been issued for research institutes...